Calcium Chloride Injection, Solution
NDC Package 76483-108-02

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Calcium Chloride injection is indicated for the treatment of adult and pediatric patients with acute symptomatic hypocalcemia.Limitations of UseThe safety and effectiveness of calcium chloride injection for long-term use has not been established. This formulation utilizes a injection, solution delivery system. Marketed by Square Pharmaceuticals Plc., this product is identified by NDC 76483-108 and is authorized under FDA application ANDA217463.

Identification & Billing

NDC Package Code
76483-108-02
Package Description
10 VIAL in 1 BOX / 10 mL in 1 VIAL (76483-108-01)
Product Code
76483-108
11-Digit Billing Format
76483010802
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Calcium Chloride
Non-Proprietary Name
Calcium Chloride
Substance Name
Calcium Chloride
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
CALCIUM CHLORIDE 100 mg/mL
Pharmacologic Class
Usage Information
Calcium chloride injection is indicated for the treatment of adult and pediatric patients with acute symptomatic hypocalcemia.Limitations of UseThe safety and effectiveness of calcium chloride injection for long-term use has not been established.

Regulatory & Marketing

Labeler Name
Square Pharmaceuticals Plc.
Product Type
Human Prescription Drug
FDA Application #
ANDA217463
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
01-15-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 76483-108-02 identifies a specific commercial package of 10 vial in 1 box / 10 ml in 1 vial (76483-108-01) of Calcium Chloride, a human prescription drug labeled by Square Pharmaceuticals Plc.. This injection, solution is formulated for intravenous use and contains calcium chloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Square Pharmaceuticals Plc. on January 15, 2026. The current certification is valid through December 31, 2027.

How is this Square Pharmaceuticals Plc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 76483010802. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
76483-108-02
11-Digit CMS (5-4-2)
76483-0108-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.